We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Publishes Revised Notice of PDUFA Fee Increases for Fiscal 2022
FDA Publishes Revised Notice of PDUFA Fee Increases for Fiscal 2022
Less than two weeks after abruptly withdrawing a notice announcing a double-digit increase in user fees for drugmakers under the Prescription Drug User Fee Act (PDUFA), the FDA has issued the notice with reductions in the proposed fees.